DEFA14A: Privia Health Clarifies Board Structure Stance Ahead of 2025 Annual Meeting

Privia Health addresses concerns raised by Institutional Shareholder Services (ISS) regarding its classified board structure, reaffirming its intention to evaluate the board's feasibility on an ongoing basis.

Summary

• Privia Health Group, Inc. is providing clarifications regarding its classified board structure in connection with its 2025 Annual Meeting of Stockholders.
• The company's position on the classified board has not changed, and it intends to evaluate its feasibility on an ongoing basis.
• ISS recommended a WITHHOLD vote for governance committee member Pamela Kimmet due to the board's failure to remove or sunset the classified board.
• Privia Health clarifies that the removal of a statement regarding not maintaining a classified board in perpetuity from the 2024 proxy statement was not intended as a substantive change.
• Stockholders representing approximately 11% of outstanding shares expressed a positive view of the classified board at this time.
• The board believes the classified board provides protection against disruptions from groups with short-term objectives.
• The board is committed to strong corporate governance and has seated five new directors and removed supermajority vote requirements since its IPO.
• The board will review relevant facts and circumstances, including changes in market capitalization, industry evolutions, and stockholder feedback, to evaluate the classified board.
• The company encourages stockholders to vote FOR all proposals at the 2025 Annual Meeting.

Sentiment

Score: 6

Explanation: The document is neutral to slightly positive. While there are concerns raised by ISS, the company is actively addressing them and engaging with stockholders. The board's commitment to corporate governance and ongoing evaluation of the classified board are positive signals.

Positives

• Privia Health is actively engaging with stockholders to gather feedback on corporate governance matters.
• The board is committed to strong corporate governance and has taken steps to refresh board composition and remove supermajority vote requirements.
• The company is transparently communicating its position on the classified board and addressing concerns raised by ISS.
• Stockholders representing approximately 11% of outstanding shares expressed a positive view of the classified board.

Negatives

• ISS recommended a WITHHOLD vote for a governance committee member due to concerns about the classified board.
• The company's classified board structure has raised concerns among some stakeholders regarding corporate governance.

Risks

• The company's classified board structure may continue to face scrutiny from ISS and other stakeholders.
• Failure to address concerns about the classified board could negatively impact stockholder support for management and board members.
• The healthcare industry and physician enablement space remains fragmented and turbulent, which could impact the company's performance.
• The company's competitive landscape continues to shift as various types of competitors acquire physician practices.

Future Outlook

The board intends to continue to evaluate the feasibility of the classified board on an ongoing basis with input from stockholders, considering factors such as market capitalization, industry evolutions, and stockholder landscape.

Management Comments

• The company's position with respect to its classified board structure has not changed and it does not intend to maintain a classified board structure in perpetuity.
• The board intends to continue to evaluate the feasibility of the classified board on an ongoing basis with input from stockholders.
• The board believes that the classified board provides protection against potential disruptions caused by groups with short-term objectives and allows the company to focus on its long-term success and maximization of value for stockholders.

Industry Context

The healthcare industry and physician enablement space remains fragmented and turbulent, and the company's competitive landscape continues to shift as various types of competitors acquire physician practices. This context informs the board's decision to maintain the classified board at this time.

Comparison to Industry Standards

• It is difficult to compare Privia Health's governance structure directly to industry standards without knowing the specific peer group.
• However, classified boards are becoming less common among publicly traded companies, particularly those with larger market capitalizations.
• Many companies, such as UnitedHealth Group and CVS Health, have declassified their boards to align with shareholder preferences for annual director elections.
• Privia Health's smaller market capitalization and relatively short time as a public company may justify the board's current position, but it will need to demonstrate a clear path towards declassification as the company matures.

Stakeholder Impact

• The company's classified board structure could impact stockholders' ability to influence board composition.
• The board's decision to maintain the classified board is intended to protect the company from disruptions and focus on long-term value creation for stockholders.
• The company's engagement with stockholders and commitment to corporate governance are intended to build trust and confidence among stakeholders.

Next Steps

• Stockholders will vote on proposals at the 2025 Annual Meeting on May 21, 2025.
• The board will continue to evaluate the feasibility of the classified board on an ongoing basis with input from stockholders.

Key Dates

Keywords

classified board, corporate governance, proxy statement, ISS, stockholders, Privia Health, annual meeting